New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 17, 2014
08:08 EDTNRXNephrogenex initiated with a Buy at Aegis
Aegis initiated Nephrogenex with a Buy rating and $25 price target. The analyst believes if Nephrogenex's Pyridorin interim data expected before the end of 2015 is positive, it could result in a transformative licensing agreement or acquisition of the company.
News For NRX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 13, 2014
07:08 EDTNRXNephrogenex announces presentation of Phase 3 Pyridorin Pioneer program
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use